Fig. 3From: Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with RivaroxabanROC curves. ROC curves for the prediction of Rivaroxaban concentration > 50 ng/mL A; LC-MS/MS and B; Anti-FXaBack to article page